| No (N=45) |
Yes (N=17) |
P-value | |
|---|---|---|---|
| Age (years) | |||
| Mean (SD) | 57.0 (8.64) | 54.5 (13.0) | 0.273 |
| Median [Min, Max] | 58.0 [42.0, 73.0] | 56.0 [24.0, 79.0] | |
| Operation_history | |||
| Direct_surgery | 33 (73.3%) | 7 (41.2%) | 0.0391 |
| Surgery_after_neoadjuvant | 12 (26.7%) | 10 (58.8%) | |
| Clinical_stage | |||
| II | 2 (4.4%) | 1 (5.9%) | 0.182 |
| III | 25 (55.6%) | 5 (29.4%) | |
| IV | 18 (40.0%) | 11 (64.7%) | |
| TMB_group | |||
| High | 1 (2.2%) | 1 (5.9%) | 1 |
| Low | 44 (97.8%) | 16 (94.1%) | |
| Planting_metastasis | |||
| No | 3 (6.7%) | 1 (5.9%) | 1 |
| Yes | 42 (93.3%) | 16 (94.1%) | |
| Lymph.node_metastasis | |||
| No | 18 (40.0%) | 6 (35.3%) | 0.962 |
| Yes | 27 (60.0%) | 11 (64.7%) |